Detalhe da pesquisa
1.
Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.
Br J Cancer
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720046
2.
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).
Br J Cancer
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38866963
3.
Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective.
Gynecol Oncol
; 187: 227-234, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38823307
4.
Demographic, clinical, and sociocognitive determinants related to physical activity and dietary intake in patients with ovarian cancer: A cross-sectional study.
Gynecol Oncol
; 183: 39-46, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503140
5.
Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes.
Int J Gynecol Cancer
; 34(5): 722-729, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460968
6.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(10): 1109-1118, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708912
7.
Exploring international differences in ovarian cancer care: a survey report on global patterns of care, current practices, and barriers.
Int J Gynecol Cancer
; 33(10): 1612-1620, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591611
8.
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.
Aust N Z J Obstet Gynaecol
; 63(5): 702-708, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259677
9.
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Int J Cancer
; 151(8): 1394-1404, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583992
10.
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?
Curr Opin Oncol
; 34(5): 497-503, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838205
11.
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
Gynecol Oncol
; 167(3): 547-556, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273925
12.
Psychological impact of referral to an oncology hospital on patients with an ovarian mass.
Int J Gynecol Cancer
; 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600495
13.
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
N Engl J Med
; 378(3): 230-240, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342393
14.
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Gynecol Oncol
; 159(3): 706-711, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33019981
15.
Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
Cancer
; 125 Suppl 24: 4587-4593, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967678
16.
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
Int J Gynecol Cancer
; 29(8): 1304-1310, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515411
17.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer - Authors' reply.
Lancet Oncol
; 24(12): e458, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040000
18.
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2).
Ann Surg Oncol
; 30(4): 1950-1952, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581719
19.
Future of HIPEC for ovarian cancer.
BJOG
; 130(2): 135-140, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073560
20.
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
Int J Cancer
; 151(11): 2057-2058, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857410